Dihydroartemisinin (DHA), the main active derivative of artemisinin, has been documented to induce autophagy in a dose-dependent manner by reducing Akt phosphorylation and suppressing the Akt/mTOR signaling pathway, which could lead to the inhibition of ESCC cell migration 152. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.